Registration Dossier

Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Tributyl borate is rapidly hydrolyzed to Boric acid and n-Butanol in the presence of water or moisture in the air (18.3 sec at 21°C). Reliable endpoint data of the hydrolysis products n-Butanol and Boric acid are used, which is entirely appropriate to draw conclusions on the acute toxicity of Tributyl borate by the oral route:

1) Hydrolysis product n-Butanol

LD50 in female rats: 2290 mg/kg bw.

2) Hydrolysis product Boric acid

- LD50 in male rats: 3450 mg/kg bw (2950 - 4040 mg/kg bw);

- LD50 in female rats 4080 mg/kg bw (3640 - 4560 mg/kg bw).

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Referenceopen allclose all

Endpoint:
acute toxicity: oral
Type of information:
other: experimental study on hydrolysis product Boric acid
Adequacy of study:
key study
Study period:
No data
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Meets generally accepted scientific standards with acceptable restrictions.
Qualifier:
according to guideline
Guideline:
other: No data
Deviations:
not specified
Principles of method if other than guideline:
Boric acid was administered orally by gavage to six groups of five male and five female albino Sprague-Dawley rats. The test material was administered as a 50 % w/v suspension in 0.5 % aqueous methyl cellulose at dosage levels of 2.0; 2.5; 3.16; 3.98; 5.01 and 6.31 g/kg bw. Rats were fasted for a period of 3 to 4 h prior to dosage. Animals were observed for mortality and toxic effects at 1, 2, 4, and 24 h and once daily after for a total of 14 days. At the end of the observation period the surviving animals were weighed sacrificed and autopsies were performed.
GLP compliance:
no
Remarks:
Study pre-dates GLP
Test type:
standard acute method
Limit test:
no
Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: Males: 267 - 302 g; Females: 214 - 248 g
Route of administration:
oral: gavage
Vehicle:
other: 0.5 % aqueous methyl cellulose
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 50 % w/v

MAXIMUM DOSE VOLUME APPLIED: 3450 - 4080 mg/kg bw
Doses:
2.0; 2.5; 3.16; 3.98; 5.01 and 6.31 g/kg bw.
No. of animals per sex per dose:
Five animals/group; no further data
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: Yes
- Other examinations performed: Clinical signs
Statistics:
Litchfield and Wilcoxon
Sex:
male
Dose descriptor:
LD50
Effect level:
3 450 mg/kg bw
Based on:
test mat.
95% CL:
2 950 - 4 040
Remarks on result:
other: mg boric acid/kg
Sex:
female
Dose descriptor:
LD50
Effect level:
4 080 mg/kg bw
Based on:
test mat.
95% CL:
3 640 - 4 560
Remarks on result:
other: mg boric acid/kg bw
Mortality:
No data
Clinical signs:
Symptoms include sings of CNS depression, ataxia, convulsions, laboured breathing or rapid respiration; blood crust around nose, marked diarrhoea and ptosis.
Body weight:
No data
Gross pathology:
Autopsies indicated congestion of lungs, kidneys and adrenals; inflammation of the pyloric portion of stomach and small intestine.
Other findings:
No data
Interpretation of results:
other: EU-GHS criteria not met
Conclusions:
The acute oral LD50 of boric acid for male albino rats was 3450 (2950 - 4040) mg boric acid/kg, equivalent to 604 mg B/kg bw. In female albino rats the acute oral LD50 of boric acid was 4080 (3640 - 4560) mg boric acid/kg, equivalent to 714 mg B/kg bw.
Endpoint:
acute toxicity: oral
Type of information:
other: experimental study on hydrolysis product n-Butanol
Adequacy of study:
key study
Study period:
1967
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: This study was conducted prior to GLP and test guidelines, but sufficient data is available for interpretation of results.
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Principles of method if other than guideline:
Test material was administered by oral gavage to rats at various dose levels. Survivors were observed for 14 days after dosing.
GLP compliance:
no
Remarks:
performed prior to GLP
Test type:
standard acute method
Limit test:
no
Species:
rat
Strain:
other: Harlan Wistar
Sex:
female
Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Doses:
Dosage levels differ by a factor of 2 in a geometric series.
No. of animals per sex per dose:
Number of female rats used not stated in report but typically 6 rats are used/dose level.
Control animals:
no
Sex:
female
Dose descriptor:
LD50
Effect level:
2.83 mL/kg bw
Based on:
test mat.
Remarks on result:
other: original value
Sex:
female
Dose descriptor:
LD50
Effect level:
ca. 2 292 mg/kg bw
Based on:
test mat.
Remarks on result:
other: converted value (calculated with a density 0.81 g/mL)

No additional information available.

Interpretation of results:
other: EU-GHS criteria not met
Conclusions:
LD50 in female rats: 2.83 ml/kg, corresponding to 2290 mg/kg bw
Executive summary:

The acute oral toxicity of n-butanol was determined in a study comparable to OECD TG 401.

60-day-old female Harlan Wistar rats were dosed with the test material at various dose levels per gavage. The acute LD50 value was 2.83 mL/kg bw in female rats, corresponding to 2290 mg/kg bw (calculated with a density of 0.81 g/mL). No further data were available.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification